ZP-7570
- Generic Name
- ZP-7570
A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570
- First Posted Date
- 2023-08-21
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Zealand Pharma
- Target Recruit Count
- 84
- Registration Number
- NCT06000891
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, North Rhine-Westphalia, Germany
Dapiglutide for the Treatment of Obesity
Phase 2
Active, not recruiting
- Conditions
- ObesityInflammation
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-03-29
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- University Hospital, Gentofte, Copenhagen
- Target Recruit Count
- 54
- Registration Number
- NCT05788601
- Locations
- 🇩🇰
Center for Clinical Metabolic Research, Herlev-Gentofte Hospital, Hellerup, Denmark
A Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570
- First Posted Date
- 2020-11-03
- Last Posted Date
- 2021-09-02
- Lead Sponsor
- Zealand Pharma
- Target Recruit Count
- 40
- Registration Number
- NCT04612517
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, North Rhine-Westphalia, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath